NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 7980.
The investigation concerns whether Masimo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 17, 2023, Masimo issued a press release announcing its preliminary revenue results for the second quarter of 2023. Masimo advised that it anticipates revenue of between $453 million and $457 million for the quarter, significantly less than the $540.87 million consensus estimate. Masimo attributed the lower-than-expected revenue to a drop in healthcare revenue caused by delays in large orders, falling single-patient use sensor sales, lower customer conversions and decreasing demand for its products from hospitals.
On this news, Masimo’s stock price fell $29.43 per share, or 20%, to close at $117.73 on July 18, 2023.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Robert S. Willoughby
888-476-6529 ext. 7980